ArticleAnnals of surgical oncology2026

ASO Author Reflections: Neoadjuvant Chemotherapy Prior to CRS/HIPEC for Metachronous Colorectal Peritoneal Metastases: No Survival Gain and Increased Perioperative Risk.

Hannah Bank et al.PubMed ↗Publisher ↗

No numbers read from the abstract.